A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
- PMID: 31044564
- PMCID: PMC6603397
- DOI: 10.1002/mgg3.689
A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
Abstract
Background: Liver transplantation is an effective therapy for end-stage liver diseases and acute liver failure. After the operation, however, recipients may suffer grafts loss induced by alloimmune reaction, which is termed as acute allograft rejection. The interaction between costimulatory molecules, CD276, and its ligand, TREML2, promotes T cell-mediated immune response, as well as acute or chronic allograft rejection. Our research aimed at correlating genetic polymorphisms of CD276/TREML2 with acute rejection, and evaluating its prognostic value of acute rejection after liver transplantation.
Methods: The study enrolled a total of 388 recipients. Among them, acute allograft rejection was observed in 54 cases. We performed single nucleotide polymorphism genotyping of CD276, including rs11072431, rs11574495, rs12593558, rs12594627, rs2127015, rs3816661 and rs7176654, and TREML2, including rs4714431, rs6915083, rs7754593, and rs9394767 from preoperative peripheral blood genome DNA.
Results: We found rs2127015 of CD276, rs6915083 and rs7754593 of TREML2, and HBV infection as well were associated with acute rejection. And, rs2127015 influences CD276 expression. Moreover, we established a risk assessment model, composited by statistically proved risk factors.
Conclusion: By integrating both clinical and genetic variables, liver transplant recipients can be categorized into different risk groups, and might benefit from individualized therapies.
Keywords: CD276; SNP; acute rejection; costimulatory molecule; liver transplantation.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures




Similar articles
-
Genetic polymorphism of interferon regulatory factor 5 (IRF5) correlates with allograft acute rejection of liver transplantation.PLoS One. 2014 Apr 30;9(4):e94426. doi: 10.1371/journal.pone.0094426. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2019 Jul 31;14(7):e0220815. doi: 10.1371/journal.pone.0220815. PMID: 24788560 Free PMC article. Retracted.
-
Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.Transplant Proc. 2011 Jul-Aug;43(6):2224-6. doi: 10.1016/j.transproceed.2011.05.011. Transplant Proc. 2011. PMID: 21839239
-
CD28 gene polymorphisms and acute cellular rejection after liver transplantation.Hum Immunol. 2020 Dec;81(12):675-678. doi: 10.1016/j.humimm.2020.10.002. Epub 2020 Oct 20. Hum Immunol. 2020. PMID: 33097290
-
Genetic Polymorphism in Cytokines and Costimulatory Molecules in Stem Cell and Solid Organ Transplantation.Clin Lab Med. 2019 Mar;39(1):107-123. doi: 10.1016/j.cll.2018.10.002. Epub 2018 Dec 24. Clin Lab Med. 2019. PMID: 30709500 Review.
-
Association between IL-4 polymorphism and acute rejection of solid organ allograft: a meta-analysis.Gene. 2013 Jan 15;513(1):14-21. doi: 10.1016/j.gene.2012.10.028. Epub 2012 Oct 26. Gene. 2013. PMID: 23107766 Review.
Cited by
-
Proteome of Personalized Tissue-Engineered Veins.ACS Omega. 2024 Mar 19;9(13):14805-14817. doi: 10.1021/acsomega.3c07098. eCollection 2024 Apr 2. ACS Omega. 2024. PMID: 38585136 Free PMC article.
-
Impact of human leukocyte antigen mismatch between donor-recipient on acute rejection in liver transplantation using next-generation sequencing: a single-center study.Front Immunol. 2025 May 20;16:1576815. doi: 10.3389/fimmu.2025.1576815. eCollection 2025. Front Immunol. 2025. PMID: 40463387 Free PMC article.
-
Importance of genetic polymorphisms in liver transplantation outcomes.World J Gastroenterol. 2020 Mar 28;26(12):1273-1285. doi: 10.3748/wjg.v26.i12.1273. World J Gastroenterol. 2020. PMID: 32256016 Free PMC article. Review.
References
-
- Bitetto, D. , Fabris, C. , Falleti, E. , Fornasiere, E. , Avellini, C. , Cmet, S. , & Toniutto, P. (2012). Recipient interleukin‐28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: Role of the calcineurin inhibitor used. Transplantation, 93(10), 1038–1044. 10.1097/TP.0b013e31824df7f3 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials